Go to content
UR Home

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)

Witt, M., Grunke, M., Proft, F., Bäuerle, M., Aringer, M., Burmester, G., Chehab, B., Fiehn, C., Fischer-Betz, R. and Fleck, Martin (2013) Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID). Lupus 22, pp. 1143-1149.

[img]
Preview
License: Allianz- bzw. Nationallizenz
PDF - Published Version
Download (242kB)
Date of publication of this fulltext: 26 Aug 2016 05:35

at publisher (via DOI)


Abstract

Objective The objective of this article is to evaluate the safety and clinical outcome of rituximab treatment in systemic lupus erythematosus (SLE) patients refractory to standard of care therapy in a real-life setting in Germany. Methods The GRAID registry included patients with different autoimmune diseases who were given off-label treatment with rituximab. Data on safety and clinical response ...

plus


Export bibliographical data



Item type:Article
Date:2013
Institutions:Medicine > Lehrstuhl für Innere Medizin I
Identification Number:
ValueType
10.1177/0961203313503912DOI
Keywords:Systemic lupus erythematosus; rituximab; efficacy; safety;Blymphocytes; cohort studies
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:34472
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons